NP001, Alzheimer's Disease, and Blood Markers of Inflammation
Clinical trial NCT03179501 · TERMINATED
Trial details
- NCT number
- NCT03179501
- Sponsor
- Beau Nakamoto
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-01
- Primary completion
- 2018-07-31
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.